Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

Go back to Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

Repligen (RGEN) Tops Q3 EPS by 14c, Raises FY Guidance

October 28, 2021 7:37 AM EDT

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.78, $0.14 better than the analyst estimate of $0.64. Revenue for the quarter came in at $178.2 million versus the consensus estimate of $163.97 million.

GUIDANCE:

Repligen sees FY2021 EPS of $2.86-$2.91, versus the consensus of $2.68. Repligen sees... More